Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type |
Therapeutic or Technology![]() |
Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
COVID-19 | Adult Stem Cell | Vaccine | Stanford |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Vaccine | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Retinitis Pigmentosa | Therapeutic Approach | jCyte |
![]() |
Clinical Trial, Phase 2 | ||
Spinal Cord Injury | Embryonic Stem Cell | Therapeutic Approach | UCSD |
![]() |
Development Candidate, Research Insights | |
COVID-19, Respiratory Disorders |
iPS Cell | Small molecule therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | iPS Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | iPS Cell | Small molecule therapy | Scripps |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | iPS Cell | Small molecule therapy | USC |
![]() |
Development Candidate, Proof of Concept | |
Skeletal/Smooth Muscle disorders | Adult Stem Cell | Small molecule therapy | Stanford |
![]() |
Proof of Concept | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
COVID-19 | Adult Stem Cell | Small molecule therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Osteonecrosis | Adult Stem Cell | Small molecule therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Vision Loss | iPS Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Small molecule therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Colon Cancer | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Autism | iPS Cell | Small molecule therapy | Scripps |
![]() |
Development Candidate, Proof of Concept | |
COVID-19, Respiratory Disorders |
iPS Cell | Small molecule therapy | Sanford-Burnham |
![]() |
Development Candidate, Proof of Concept | |
Hearing Loss | Adult Stem Cell | Protein/peptide therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Bladder or Urinary Tract Disorder, Incontinence |
iPS Cell | Personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
HIV/AIDS | Personalized cell therapy | COH |
![]() |
IND | ||
Age-related macular degeneration | iPS Cell | Personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Corneal Damage | Adult Stem Cell | Personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Multiple Myeloma | Adult Stem Cell | Personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Amyotrophic Lateral Sclerosis | Adult Stem Cell | Personalized cell therapy | BrainStorm |
![]() |
Clinical Trial, Phase 3 | |
Amyotrophic Lateral Sclerosis | iPS Cell | Nucleic acid based therapy | USC |
![]() |
Development Candidate, Proof of Concept | |
COVID-19, Respiratory Disorders |
Adult Stem Cell | Model system development | UCLA |
![]() |
Development Candidate, Proof of Concept, Tool/Resources/Bottleneck | |
COVID-19 | iPS Cell | Model system development | UC Berkeley |
![]() |
Proof of Concept | |
Hearing Loss | iPS Cell | Model system development | USC |
![]() |
Proof of Concept, Tool/Resources/Bottleneck | |
HIV-related Lymphoma, HIV/AIDS |
Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Immune Disease, X-linked Chronic Granulomatous Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Pre-IND/IDE or Equivalent | |
Canavan Disease | iPS Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML), Multiple Myeloma |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Multiple Myeloma | Adult Stem Cell | Gene-modified, personalized cell therapy | Poseida Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | Boston Children's Hospital |
![]() |
Clinical Trial, Phase 2 | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
IND | |
Epidermolysis Bullosa | iPS Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Development Candidate, Proof of Concept | |
Blood Disorders, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Proof of Concept | |
HIV/AIDS, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Bone or Cartilage Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | Rocket Pharmaceuticals, Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Heart Disease, Danon Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Hyper IgM Syndrome, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
IND | |
Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | St. Jude |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Blood Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 |